FOLH1 and neoplasm: Additionally, developing more sensitive and specific detection technologies (such as nano-flow cytometry) and enriching tumor-specific exosomes in conjunction with surface markers (such as prostate-specific membrane antigen, PSMA) will enhance the sensitivity and specificity of detection.